South San Francisco, CA September 1, 2016 Genentech Press Release Phase III Study Showed Genentech’s Cancer Immunotherapy TECENTRIQTM (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy TECENTRIQ showed significant improvement…